Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Chang, Kah H ^a   Brodie, Rachel ^a   Choong, Mei A ^a   Sweeney, Karl J ^a   Kerin, Michael J ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE TO HEALTH; CANCER PATIENT; CANCER THERAPY; CONTROLLED STUDY; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HUMAN; INCOME; IRELAND; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIVATE HEALTH INSURANCE; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; RELIGION; AGED; CROSS-SECTIONAL STUDY; MIDDLE AGED; NEOPLASM; PATIENT ATTITUDE; RISK ASSESSMENT; STATISTICS;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 79956274767     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-196     Document Type: Article

References (38)

1. World Health Organization WHO traditional medicine strategy 2002-2005. World Health Organization., http://apps.who.int/medicinedocs/en/d/Js2297e/
2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. N Engl J Med 1993, 328:246-252. 10.1056/NEJM199301283280406, 8418405.
3. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998, 280:1569-1575. 10.1001/jama.280.18.1569, 9820257.
4. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000, 18:2505-2514.
5. Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005, 23:2645-2654.
6. Miller DR, Anderson GT, Stark JJ, Granick JL, Richardson D. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998, 16:3649-3655.
7. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF, Krook JE, Rowland KM, Mazurczak MA, Berg AR, Kim GP, . North Central cancer Treatment Group Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment group trial. Cancer 2005, 104:176-182. 10.1002/cncr.21107, 15912493, North Central cancer Treatment Group.
8. Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of St. John's wort on irinotecan metabolism: St. John's Wort--More implications for cancer patients. J Natl Cancer Inst 2002, 94:1247-1249.
9. Kristoffersen AE, Fonnebo V, Norheim AJ. Do cancer patients with a poor prognosis use complementary and alternative medicine more often than others?. J Altern Complement Med 2009, 15:1115-1120. 10.1089/acm.2009.0083, 19848548.
10. Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol 2007, 25:548-554. 10.1200/JCO.2005.03.9800, 17290064.
11. Amin M, Glynn F, Rowley S, O'Leary G, O'Dwyer T, Timon C, Kinsella J. Complementary medicine use in patients with head and neck cancer in Ireland. Eur Arch Otorhinolaryngol 2010, 267:1291-1297. 10.1007/s00405-010-1223-1, 20229270.
12. Richardson MA, Masse LC, Nanny K, Sanders C. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer 2004, 12:797-804. 10.1007/s00520-004-0677-3, 15378417.
13. Hyodo I, Eguchi K, Nishina T, Endo H, Tanimizu M, Mikami I, Takashima S, Imanishi J. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine. Cancer 2003, 97:2861-2868. 10.1002/cncr.11402, 12767101.
14. Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR. Knowledge of and attitudes toward complementary and alternative therapies: a national multicentre study of oncology professionals in Norway. Eur J Cancer 2004, 40:529-535. 10.1016/j.ejca.2003.11.011, 14962719.
15. Hyodo I, Eguchi K, Takigawa N, Segawa Y, Hosokawa Y, Kamejima K, Inoue R. Psychological impact of informed consent in hospitalized cancer patients: A sequential study of anxiety and depression using the hospital anxiety and depression scale. Support Care Cancer 1999, 7:396-399. 10.1007/s005200050299, 10541981.
16. Ezzo J, Vickers A, Richardson MA, Allen C, Dibble SL, Issell B, Lao L, Pearl M, Ramirez G, Roscoe JA, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G. Acupuncture-Point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol 2005, 23:7188-7198. 10.1200/JCO.2005.06.028, 16192603.
17. Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database of Systematic Reviews 2005, 1:CD004540.
18. Caraballoso M, Sacristan M, Serra C, Bonfill X. Drugs for preventing lung cancer in healthy people. Cochrane Database of Systematic Reviews 2003, 2:CD002141.
19. Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database of Systematic Reviews 2007, 1:CD004597.
20. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. British Journal of Anaesthesia 2007, 84:367-371.
21. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994, 309:107-111. 2540528, 8038643.
22. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996, 347:569-573. 10.1016/S0140-6736(96)91271-4, 8596318.
23. Fox P, Coughlan B, Butler M, Kelleher C. Complementary alternative medicine (CAM) use in Ireland: a secondary analysis of SLAN data. Complement Ther Med 2010, 18:95-103. 10.1016/j.ctim.2010.02.001, 20430292.
24. Rees RW, Feigal I, Vickers A, Zollman C, McGurk R, Smith C. Prevalence of complementary therapy use by women with breast cancer: a population-based survey. Eur J Cancer 2000, 36:1359-1364. 10.1016/S0959-8049(00)00099-X, 10899648.
25. Paltier O, Avitzour M, Peretz T, Cherny N, Kaduri L, Pfeffer RM, Wagner N, Soskolne V. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 2001, 19:2439-2448.
26. Malassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005, 16:655-663. 10.1093/annonc/mdi110, 15699021.
27. Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors. Cancer 2008, 113:1048-1057. 10.1002/cncr.23659, 18680170.
28. Corner J, Yardley J, Maher EJ, Roffe L, Young T, Maslin-Prothero S, Gwilliam C, Haviland J, Lewith G. Patterns of complementary and alternative medicine use among patients undergoing cancer treatment. Eur J Cancer Care 2009, 18:271-279.
29. Munstedt K, Kirsch K, Milch W, Sachsse S, Vahrson H. Unconventional cancer therapy: Survey of patients with gynecological malignancy. Arch Gynecol Obstet 1996, 258:81-88.
30. Begbie SD, Kerestes ZL, Bell DR. Patterns of alternative medicine use by cancer patients. Med J Aust 1996, 165:545-548.
31. Risberg T, Lund E, Wist E, Dahl O, Sundstrøm S, Andersen OK, Kaasa S. The use of non-proven therapy among patients treated in Norwegian oncological departments: A cross-sectional national multicenter study. Eur J Cancer 1995, 31A:1785-1789.
32. Hirai K, Komura K, Tokoro A, Kuromaru T, Ohshima A, Ito T, Sumiyoshi Y, Hyodo I. Psychological and behavioral mechanisms influencing the use of complementary and alternative medicine (CAM) use in cancer patients. Ann Oncol 2008, 19:49-55.
33. Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior. Cancer 2000, 89:873-880. 10.1002/1097-0142(20000815)89:4<873::AID-CNCR21>3.0.CO;2-K, 10951352.
34. Gratus C, Wilson S, Greenfield SM, Damery SL, Warmington SA, Grieve R, Steven NM, Routledge P. The use of herbal medicines by people with cancer: a qualitative study. BMC Complement Altern Med 2009, 9:14. 10.1186/1472-6882-9-14, 2685766, 19442268.
35. Shih V, Chiang JYL, Chan A. Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients. Ann Oncol 2009, 20:752-757. 10.1093/annonc/mdn659, 19150956.
36. Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 2004, 12:90-98. 10.1016/j.ctim.2004.09.006, 15561518.
37. Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. 2001, World Health Organization.
38. Owen DK, Lewith G, Stephens CR. Can doctors respond to patients' increasing interest in complementary and alternative medicine?. BMJ 2001, 322:154-158. 10.1136/bmj.322.7279.154, 1119418, 11159576.